VALIDATION OF CNS-IPI AND CORRELATION WITH CELL OF ORIGIN PROFILE IN A RETROSPECTIVE SERIES OF DLBCL PATIENTS TREATED WITH R-CHOP IN A SINGLE INSTITUTION

被引：0
|
作者：
Castellino, A.
Novo, M.
Chiappella, A.
Ciochetto, C.
Vittone, F.
Botto, B.
Cavallo, F.
Orsucci, L.
Boccomini, C.
Evangelista, A.
Ghione, P.
Nicolosi, M.
Santambrogio, E.
Ciccone, G.
Novero, D.
Vitolo, U.
机构：
[1] Univ Torino, Ematol, Turin, Italy
[2] AOU Citta Salute & Sci, Anat Patol, Turin, Italy
[3] AOU Citta Salute & Sci, CPO, Epidemiol Clin, Turin, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P150
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [31] Diffuse Large B-Cell Lymphoma (DLBCL) Patients with Composite Histology Have Improved Early outcome Compared to De Novo DLBCL When Treated with R-CHOP
    Maurer, Matthew J.
    Witzig, Thomas E.
    Macon, William R.
    Syrbu, Sergei I.
    Cerhan, James R.
    Allmer, Cristine
    Johnston, Patrick B.
    Link, Brain K.
    Habermann, Thomas M.
    BLOOD, 2008, 112 (11) : 974 - 974
  • [32] Publisher Correction: The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Xiaolei Wei
    Xiaoxiao Hao
    Lizhi Zhou
    Qi Wei
    Yuankun Zhang
    Weimin Huang
    Jialin Song
    Ru Feng
    Yongqiang Wei
    Scientific Reports, 9
  • [33] Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience.
    Devi, Kanta
    Shaikh, Muhammad Usman
    Ali, Natasha Bahadur
    Adil, Salman Naseem
    Khan, Maria
    Soomar, Salman Muhammad
    LEUKEMIA RESEARCH REPORTS, 2021, 16
  • [34] Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
    Xu-Monette, Zijun Y.
    Wu, Lin
    Visco, Carlo
    Tai, Yu Chuan
    Tzankov, Alexander
    Liu, Wei-min
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Zhao, X. Frank
    Choi, William W. L.
    Zhao, Xiaoying
    van Krieken, J. Han
    Huang, Qin
    Huh, Jooryung
    Ai, Weiyun
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Zhou, Fan
    Kahl, Brad S.
    Winter, Jane N.
    Xu, Wei
    Li, Jianyong
    Go, Ronald S.
    Li, Yong
    Piris, Miguel A.
    Moller, Michael B.
    Miranda, Roberto N.
    Abruzzo, Lynne V.
    Medeiros, L. Jeffrey
    Young, Ken H.
    BLOOD, 2012, 120 (19) : 3986 - 3996
  • [35] GENE EXPRESSION PROFILING (GEP) AND NOT IMMUNOCHEMICAL ALGORITHMS PREDICTS PROGNOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-CHOP
    Gutierrez, G.
    Cardesa, T.
    Climent, F.
    Mate, J.
    Mercadal, S.
    Sancho, J.
    Serrano, S.
    Escoda, L.
    Martinez, A.
    Gine, E.
    Villamor, N.
    Campo, E.
    Colomo, L.
    Lopez-Guillermo, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 108 - 109
  • [36] Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients
    Perrone, Gabriele
    Rigacci, Luigi
    Roviello, Giandomenico
    Landini, Ida
    Fabbri, Alberto
    Iovino, Lorenzo
    Puccini, Benedetta
    Cencini, Emanuele
    Orciuolo, Enrico
    Bocchia, Monica
    Bosi, Alberto
    Mini, Enrico
    Nobili, Stefania
    CANCER DRUG RESISTANCE, 2024, 7 : 2 - 14
  • [37] Assessment of Circulating Tumor DNA in Newly Diagnosed DLBCL Patients Randomly Treated By R-CHOP or R-High Dose Chemotherapy Plus Autologous Stem Cell Support
    Desmots-Loyer, Fabienne
    Rossille, Delphine
    Roussel, Mikael
    Le Gouill, Steven
    Lamy, Thierry
    Milpied, Noel
    Fest, Thierry
    BLOOD, 2021, 138
  • [38] The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady
    Chung, Joo-Seop
    Ilic, Ivana
    Leppa, Sirpa
    Seki, Ritsuko
    Uccella, Silvia
    Xia, Zu-Guang
    Butera, James N.
    BLOOD, 2010, 116 (21) : 1679 - 1679
  • [39] The T-Cell Receptor Repertoire Predicts Interim-PET in Patients with DLBCL Treated with R-CHOP: An Observational Study from a Prospective Clinical Trial
    Shanavas, Mohamed
    Hertzberg, Mark
    Hicks, Rodney J.
    Seymour, John F.
    Tobin, Joshua W. D.
    Mathews, Marina
    Francis, Santiyagu
    Vari, Frank
    Gandhi, Maher K.
    Keane, Colm
    BLOOD, 2017, 130
  • [40] Interim 18-FDG-PET/CT Does Not Predict The Outcome of Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP
    Bello, M.
    Giunta, F.
    Pregno, P.
    Ladetto, M.
    Menga, M.
    Passera, R.
    Salvi, F.
    Franceschetti, S.
    Rigacci, L.
    Vitolo, U.
    Bisi, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S213 - S213
12345